Sign up to The Irish Times Archive (1859 - 2008)My Account »

THE LARGEST global study into chronic heart failure has found that a drug made in Co Wicklow reduces death and hospitalisation due to heart failure by more than 25 per cent in at-risk patients.

The findings were outlined yesterday at the European Society of Cardiology Congress in Sweden and are being published in the latest edition of the Lancet medical journal.